SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-23-002162
Filing Date
2023-06-05
Accepted
2023-06-05 16:54:46
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 zk2329855.html 3  
1 zk2329855.xml 3 5207
  Complete submission text file 0001178913-23-002162.txt   6669
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16 KANFEY NESHARIM ST. RAMAT GAN L3 5235716
Business Address
Fatal Sigal (Reporting) CIK: 0001850994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 23993421